Published in Antivir Ther on January 01, 2008
Dissecting interferon-induced transcriptional programs in human peripheral blood cells. PLoS One (2010) 1.73
Interferons and viruses: an evolutionary arms race of molecular interactions. Trends Immunol (2015) 1.22
Temporal and spatial resolution of type I and III interferon responses in vivo. J Virol (2010) 1.18
Expression profiles of human interferon-alpha and interferon-lambda subtypes are ligand- and cell-dependent. Immunol Cell Biol (2012) 1.08
IFN-α subtypes: distinct biological activities in anti-viral therapy. Br J Pharmacol (2013) 1.02
Beta interferon regulation of glucose metabolism is PI3K/Akt dependent and important for antiviral activity against coxsackievirus B3. J Virol (2014) 0.91
IFN-alpha expression and antiviral effects are subtype and cell type specific in the cardiac response to viral infection. Virology (2009) 0.90
Tissue-specific interferon alpha subtype response to SIV infection in brain, spleen, and lung. J Interferon Cytokine Res (2012) 0.80
Production and characterization of thirteen human type-I interferon-α subtypes. Protein Expr Purif (2014) 0.79
MDA5 Induces a Stronger Interferon Response than RIG-I to GCRV Infection through a Mechanism Involving the Phosphorylation and Dimerization of IRF3 and IRF7 in CIK Cells. Front Immunol (2017) 0.76
Induction of IFN-α subtypes and their antiviral activity in mumps virus infection. Viral Immunol (2014) 0.75
Passive broad-spectrum influenza immunoprophylaxis. Influenza Res Treat (2014) 0.75
Lung epithelial cells have virus-specific and shared gene expression responses to infection by diverse respiratory viruses. PLoS One (2017) 0.75
Stats: multifaceted regulators of transcription. J Interferon Cytokine Res (2005) 2.02
Role of the Akt pathway in mRNA translation of interferon-stimulated genes. Proc Natl Acad Sci U S A (2008) 1.81
Interferon alfacon-1 plus corticosteroids in severe acute respiratory syndrome: a preliminary study. JAMA (2003) 1.81
Protein kinase C-delta (PKC-delta ) is activated by type I interferons and mediates phosphorylation of Stat1 on serine 727. J Biol Chem (2002) 1.72
Contribution of interferon-beta to the murine macrophage response to the toll-like receptor 4 agonist, lipopolysaccharide. J Biol Chem (2006) 1.70
Sex affects immunity. J Autoimmun (2012) 1.68
Fibrocyte activation in rheumatoid arthritis. Rheumatology (Oxford) (2009) 1.68
Chemokines: attractive mediators of the immune response. Semin Immunol (2003) 1.66
Circulating fibrocytes contribute to the pathogenesis of collagen antibody-induced arthritis. Arthritis Rheum (2012) 1.65
Review: IFN-alpha/beta receptor interactions to biologic outcomes: understanding the circuitry. J Interferon Cytokine Res (2002) 1.55
Regulatory effects of mammalian target of rapamycin-activated pathways in type I and II interferon signaling. J Biol Chem (2006) 1.41
Protective role for interferon-beta in coxsackievirus B3 infection. Circulation (2004) 1.40
Therapeutic implications for interferon-alpha in arthritis: a pilot study. J Rheumatol (2003) 1.39
Activation of the p70 S6 kinase and phosphorylation of the 4E-BP1 repressor of mRNA translation by type I interferons. J Biol Chem (2003) 1.36
Influenza virus non-structural protein 1 (NS1) disrupts interferon signaling. PLoS One (2010) 1.29
Sex differences in the vaccine-specific and non-targeted effects of vaccines. Vaccine (2011) 1.27
The yin and yang of viruses and interferons. Trends Immunol (2012) 1.25
Interferon-gamma engages the p70 S6 kinase to regulate phosphorylation of the 40S S6 ribosomal protein. Exp Cell Res (2004) 1.25
Activation of protein kinase C delta by IFN-gamma. J Immunol (2003) 1.25
Role of p38alpha Map kinase in Type I interferon signaling. J Biol Chem (2003) 1.23
Dual regulatory roles of phosphatidylinositol 3-kinase in IFN signaling. J Immunol (2008) 1.22
Interferon-dependent engagement of eukaryotic initiation factor 4B via S6 kinase (S6K)- and ribosomal protein S6K-mediated signals. Mol Cell Biol (2009) 1.21
Type I interferon (IFN)-dependent activation of Mnk1 and its role in the generation of growth inhibitory responses. Proc Natl Acad Sci U S A (2009) 1.17
Role of Schlafen 2 (SLFN2) in the generation of interferon alpha-induced growth inhibitory responses. J Biol Chem (2009) 1.14
Critical roles for IFN-beta in lymphoid development, myelopoiesis, and tumor development: links to tumor necrosis factor alpha. Proc Natl Acad Sci U S A (2003) 1.14
Murine hepatitis virus strain 1 produces a clinically relevant model of severe acute respiratory syndrome in A/J mice. J Virol (2006) 1.13
Engagement of protein kinase C-theta in interferon signaling in T-cells. J Biol Chem (2004) 1.10
CCL5 promotes proliferation of MCF-7 cells through mTOR-dependent mRNA translation. Biochem Biophys Res Commun (2009) 1.09
Activation of protein kinase C delta by all-trans-retinoic acid. J Biol Chem (2003) 1.06
CCL5-CCR5-mediated apoptosis in T cells: Requirement for glycosaminoglycan binding and CCL5 aggregation. J Biol Chem (2006) 1.05
Vaccinia virus activation of CCR5 invokes tyrosine phosphorylation signaling events that support virus replication. J Virol (2006) 1.04
Regulatory effects of mTORC2 complexes in type I IFN signaling and in the generation of IFN responses. Proc Natl Acad Sci U S A (2012) 1.03
Differential regulation of the p70 S6 kinase pathway by interferon alpha (IFNalpha) and imatinib mesylate (STI571) in chronic myelogenous leukemia cells. Blood (2005) 1.03
Role of the p38 mitogen-activated protein kinase pathway in the generation of the effects of imatinib mesylate (STI571) in BCR-ABL-expressing cells. J Biol Chem (2004) 1.02
Interferon: current status and future prospects in cancer therapy. J Interferon Cytokine Res (2011) 1.01
Diversity and relatedness among the type I interferons. J Interferon Cytokine Res (2004) 1.01
CCL5-mediated T-cell chemotaxis involves the initiation of mRNA translation through mTOR/4E-BP1. Blood (2008) 1.00
The schlafen family of proteins and their regulation by interferons. J Interferon Cytokine Res (2013) 0.99
Essential role for Mnk kinases in type II interferon (IFNgamma) signaling and its suppressive effects on normal hematopoiesis. J Biol Chem (2010) 0.99
Role of Stat5 in type I interferon-signaling and transcriptional regulation. Biochem Biophys Res Commun (2003) 0.96
Role of protein kinase C-delta (PKC-delta) in the generation of the effects of IFN-alpha in chronic myelogenous leukemia cells. Exp Hematol (2005) 0.94
The chemokine CCL5 regulates glucose uptake and AMP kinase signaling in activated T cells to facilitate chemotaxis. J Biol Chem (2012) 0.93
Multiparameter phospho-flow analysis of lymphocytes in early rheumatoid arthritis: implications for diagnosis and monitoring drug therapy. PLoS One (2009) 0.92
Identification of a novel antigen-presenting cell population modulating antiinfluenza type 2 immunity. J Exp Med (2010) 0.92
A structural basis for interferon-alpha-receptor interactions. FASEB J (2007) 0.91
Functional relevance of the conserved DNA-binding domain of STAT2. J Biol Chem (2005) 0.91
LAPCs promote follicular helper T cell differentiation of Ag-primed CD4+ T cells during respiratory virus infection. J Exp Med (2012) 0.91
Regulatory effects of programmed cell death 4 (PDCD4) protein in interferon (IFN)-stimulated gene expression and generation of type I IFN responses. Mol Cell Biol (2012) 0.90
Sprouty proteins are negative regulators of interferon (IFN) signaling and IFN-inducible biological responses. J Biol Chem (2012) 0.90
Role for CCR5 in dissemination of vaccinia virus in vivo. J Virol (2008) 0.88
Interferon-alpha/beta-receptor interactions: a complex story unfolding. Curr Pharm Des (2002) 0.88
Activation of protein kinase C{eta} by type I interferons. J Biol Chem (2009) 0.88
Characterization of the antiviral effects of interferon-alpha against a SARS-like coronoavirus infection in vitro. Cell Res (2006) 0.87
Regulatory effects of ribosomal S6 kinase 1 (RSK1) in IFNλ signaling. J Biol Chem (2010) 0.87
Suppression of interferon (IFN)-inducible genes and IFN-mediated functional responses in BCR-ABL-expressing cells. J Biol Chem (2008) 0.87
Dynamic accumulation of plasmacytoid dendritic cells in lymph nodes is regulated by interferon-beta. Blood (2009) 0.86
Identification of GAS-dependent interferon-sensitive target genes whose transcription is STAT2-dependent but ISGF3-independent. FEBS J (2006) 0.86
The role of circulating fibrocytes in inflammation and autoimmunity. J Leukoc Biol (2012) 0.86
Activation of mitogen-activated protein kinase kinase (MKK) 3 and MKK6 by type I interferons. J Biol Chem (2005) 0.85
The CrkL adapter protein is required for type I interferon-dependent gene transcription and activation of the small G-protein Rap1. Biochem Biophys Res Commun (2002) 0.84
Dynamic changes in clinical features and cytokine/chemokine responses in SARS patients treated with interferon alfacon-1 plus corticosteroids. Antivir Ther (2005) 0.84
Critical roles for Rictor/Sin1 complexes in interferon-dependent gene transcription and generation of antiproliferative responses. J Biol Chem (2014) 0.84
Essential role for the Mnk pathway in the inhibitory effects of type I interferons on myeloproliferative neoplasm (MPN) precursors. J Biol Chem (2013) 0.84
Interferon-β modulates type 1 immunity during influenza virus infection. Antiviral Res (2010) 0.80
Antiviral effects of interferon-β are enhanced in the absence of the translational suppressor 4E-BP1 in myocarditis induced by Coxsackievirus B3. Antivir Ther (2011) 0.80
Chemokines and cancer. Cancer Treat Res (2005) 0.79
Immunoregulatory effects of interferon-β in suppression of Th17 cells. J Interferon Cytokine Res (2013) 0.78
Interferon-inducible Stat2 activation of JUND and CLDN4: mediators of IFN responses. J Interferon Cytokine Res (2007) 0.78
Genomic DNA affinity chromatography: a technique to isolate interferon-inducible DNA binding factors. Methods Mol Med (2005) 0.77
Glomulin: a permissivity factor for vaccinia virus infection. J Interferon Cytokine Res (2012) 0.77
STAT activation in malignancies: roles in tumor progression and in the generation of antineoplastic effects of IFNs. J Interferon Cytokine Res (2013) 0.77
De novo design of nonpeptidic compounds targeting the interactions between interferon-alpha and its cognate cell surface receptor. J Med Chem (2008) 0.77
WFDC1/ps20: a host factor that influences the neutrophil response to murine hepatitis virus (MHV) 1 infection. Antiviral Res (2012) 0.76